FDA Approval of LISRAYA for Adults with Dermatomyositis – Roivant
Roivant announced that the FDA has approved LISRAYA (brepocitinib) 30 mg for the treatment of adults with dermatomyositis (DM). LISRAYA is a pill taken once daily. DM is… read more.
Roivant announced that the FDA has approved LISRAYA (brepocitinib) 30 mg for the treatment of adults with dermatomyositis (DM). LISRAYA is a pill taken once daily. DM is… read more.
New research in the International Journal of Clinical Practice suggests that workplace psychological stress may impair erectile function in young men by affecting certain stress management pathways in the brain… read more.
The risk of being hospitalised for flu or pneumonia can be reduced with a high-dose flu vaccine for older people with chronic lung disease, according to the combined… read more.
Eli Lilly and Company announced results from a real-world study of adults over 55 with overweight or obesity, which found that staying on Zepbound (tirzepatide) for weight management… read more.
NICE(UK) updated recommendation their 6 August 2026 recommendation to expand the population in line with the marketing authorisation. We also updated the technology name and title to more… read more.
Gilead Sciences, Inc. announced that the FDA approved Bixlenvo (bictegravir 75 mg/lenacapavir 50 mg), the smallest once-daily single tablet regimen (STR) for the treatment of HIV in adults… read more.
Takeda announced FDA approval of the New Drug Application (NDA) for Mimrylo (rusfertide) for the treatment of erythrocytosis in adults with polycythemia vera (PV), a blood cancer. Mimrylo… read more.
Three large studies together show that, although the number of people who smoke is declining, people are taking up smoking at a younger age and vaping has increased,… read more.
PharmaEssentia USA Corporation, a subsidiary of PharmaEssentia Corporation announced the FDA has approved BESREMi (ropeginterferon alfa-2b-njft) for the treatment of adults with essential thrombocythemia (ET), making it the… read more.
In a third of cases, AI chatbots wrongly reassure sleep apnoea patients that their symptoms are not serious, discouraging them from seeking a referral to a specialist, according… read more.
Robot-assisted knee replacement surgery is more precise than a surgeon on their own, but does not currently lead to improvements in patient outcomes, according to the RACER-Knee trial,… read more.
Automatic crash notification (ACN) systems should become a standard safety feature in every new vehicle, like seat belts and air bags, according to a new paper by members of the American… read more.